Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • RAAS
    (2)
  • Prostaglandin Receptor
    (1)
TargetMol | Tags By ResearchField
  • Endocrine system
    (2)
  • Inflammation
    (2)
  • Cancer
    (1)
  • Immune System
    (1)
Filter
Search Result
Results for "

sb252218

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Tranilast
    SB 252218, MK 341
    T269053902-12-8
    Tranilast (SB 252218), an antiallergic drug, suppresses lipid mediator and cytokine release from inflammatory cells, therefore utilized in the treatment of allergic disorders.
    • $36
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Trans-Tranilast
    Tranilast trans-
    T227070806-55-2
    Trans-Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
    • $44
    In Stock
    Size
    QTY